<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVE: Increased <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> are well known in patients suffering from malignant diseases </plain></SENT>
<SENT sid="1" pm="."><plain>In the following pilot study, we investigated the usefulness of coagulation factor VIII (FVIII) as a possible prognostic marker in patients with colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Plasma FVIII levels were measured in 79 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, correlated with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> characteristics, and compared with <z:mpath ids='MPATH_458'>normal</z:mpath> ranges of blood group (BG) 0 and BG A/AB/B and with 19 control patients </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients mean FVIII levels were elevated compared with controls (BG 0: p=0.283, BG A/AB/B: p=0.001) and <z:mpath ids='MPATH_458'>normal</z:mpath> ranges </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, mean FVIII levels varied significantly in different blood groups (p=0.002) </plain></SENT>
<SENT sid="5" pm="."><plain>UICC stage I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients presented with mean FVIII plasma levels within <z:mpath ids='MPATH_458'>normal</z:mpath> ranges, whereas UICC stage II-IV <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients presented with elevated FVIII plasma levels </plain></SENT>
<SENT sid="6" pm="."><plain>In BG A/AB/B a significantly elevated FVIII level was found in G2 compared with G1 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (p&lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with elevated carcinoembryonic antigen also showed significantly elevated FVIII levels (p=0.050) </plain></SENT>
<SENT sid="8" pm="."><plain>FVIII levels at time of surgery did not correlate with survival within the first 2 years following surgery </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: In this pilot study, we demonstrated that FVIII plasma levels are elevated in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and affected by T-stage and differentiation of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Whether FVIII is a clinical useful marker needs to be tested in a larger cohort </plain></SENT>
</text></document>